Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.36% |
| 2 | Technology | 9.28% |
| 3 | Financials | 7.68% |
| 4 | Healthcare | 6.5% |
| 5 | Industrials | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADVM
4201
DELISTED
Adverum Biotechnologies
ADVM
| $1.47M | ﹤0.01% |
324,422
-17,918
| -5% | -$52.8K |
|
4202
CALL
MasTec
MTZ
$20.2B
| $1.47M | ﹤0.01% |
6,900
+100
| +1% | +$18.3K |
|
|
QIPT
4203
DELISTED
Quipt Home Medical
QIPT
| $1.47M | ﹤0.01% |
562,532
-16,966
| -3% | -$39.2K |
|
4204
Redwire
RDW
$2.82B
| $1.47M | ﹤0.01% |
163,230
-1,140,314
| -87% | -$13.3M |
|
4205
World Acceptance Corp
WRLD
$886M
| $1.47M | ﹤0.01% |
+8,667
| New | +$1.46M |
|
4206
CALL
Amprius Technologies Warrants
AMPX.WS
$444M
| $1.46M | ﹤0.01% |
+400,000
| New | +$854K |
|
4207
RadNet
RDNT
$5.93B
| $1.46M | ﹤0.01% |
19,199
-310,406
| -94% | -$20.2M |
|
4208
PUT
CarMax
KMX
$8.89B
| $1.46M | ﹤0.01% |
32,600
+4,200
| +15% | +$251K |
|
4209
Invesco KBW Bank ETF
KBWB
$6.78B
| $1.46M | ﹤0.01% |
+18,689
| New | +$1.41M |
|
|
UCTT
4210
Ultra Clean Holdings
UCTT
$3.38B
| $1.46M | ﹤0.01% |
53,592
-28,396
| -35% | -$698K |
|
4211
Capricor Therapeutics
CAPR
$585M
| $1.46M | ﹤0.01% |
202,459
+28,611
| +16% | +$211K |
|
4212
Solid Power
SLDP
$543M
| $1.46M | ﹤0.01% |
420,170
+161,634
| +63% | +$609K |
|
4213
CALL
Joby Aviation
JOBY
$7.07B
| $1.46M | ﹤0.01% |
204,033
-82,000
| -29% | -$1.25M |
|
4214
Kimbell Royalty Partners
KRP
$1.54B
| $1.45M | ﹤0.01% |
107,724
-118,534
| -52% | -$1.67M |
|
4215
CALL
VF Corp
VFC
$5.36B
| $1.45M | ﹤0.01% |
100,400
+3,500
| +4% | +$47K |
|
4216
Atossa Therapeutics
ATOS
$26.3M
| $1.45M | ﹤0.01% |
111,243
-25,259
| -19% | -$312K |
|
|
TLN
4217
PUT
Talen Energy Corp
TLN
$14.6B
| $1.45M | ﹤0.01% |
+3,400
| New | +$1.23M |
|
|
4218
CALL
Capricor Therapeutics
CAPR
$585M
| $1.45M | ﹤0.01% |
200,500
+160,500
| +401% | +$1.18M |
|
4219
PUT
DoubleVerify
DV
$2.07B
| $1.44M | ﹤0.01% |
+120,000
| New | +$1.78M |
|
4220
Stoke Therapeutics
STOK
$2.1B
| $1.43M | ﹤0.01% |
61,048
+40,652
| +199% | +$697K |
|
4221
PUT
Takeda Pharmaceutical
TAK
$57.6B
| $1.43M | ﹤0.01% |
+97,800
| New | +$1.45M |
|
4222
Esquire Financial Holdings
ESQ
$1.38B
| $1.43M | ﹤0.01% |
+14,026
| New | +$1.38M |
|
4223
TFS Financial
TFSL
$5.02B
| $1.43M | ﹤0.01% |
108,628
+44,171
| +69% | +$584K |
|
4224
CALL
Nektar Therapeutics
NKTR
$2.55B
| $1.42M | ﹤0.01% |
25,000
-54,000
| -68% | -$1.79M |
|
|
JAMF
4225
CALL
DELISTED
Jamf
JAMF
| $1.42M | ﹤0.01% |
+132,900
| New | +$1.2M |
|
Similar funds
Israel Englander's Q3 2025 Portfolio in Review
As of Q3 2025, Israel Englander held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Israel Englander added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Israel Englander's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Israel Englander fully exited Hess in Q3 2025, selling an estimated $478M.
- Israel Englander's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Israel Englander opened 800 new positions and closed 633 in Q3 2025.
- Israel Englander's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.